Diabetes Technology Research Group

14/01/2026

D.T.R.G are recruiting for the Post-Exercise Protein Ingestion Study, which will investigate how post-exercise ingestion of protein can cause changes to blood glucose levels between completion of exercise and the first post-exercise meal in adults with diabetes. To express your interest, contact Dr Dale Morrison on dale.morrison@unimelb.edu.au or on 0413137853. Alternately, express your interest through our website - https://www.diabetestechnologyresearchgroup.com.au/the-post-exercise-protein-ingestion-study/

18/12/2025

We need you to test the new NMX7-AID system to see how the device performs during different types of exercise.

To join this research study, you must:
Be aged at least 18 years of age
Diagnosed with T1D for at least 1 year
Have used the Medtronic MiniMed™ 780G insulin pump for at least 3 months to manage your T1D.

To read more and register your interest, head to our website via this link -> https://www.diabetestechnologyresearchgroup.com.au/the-nmx7-aid-exercise-study/

17/12/2025

D.T.R.G would like to wish everyone a safe and happy holidays over the Christmas and new year period. We will be back in 2026 to deliver more cutting edge research and technology to our participants and community!

08/12/2025

It was wonderful to have TrialScreen with us on Friday to talk all things diabetes, research, and automated insulin delivery! Thank you for helping us highlight the work we do with the Australian diabetes community and the opportunities available through clinical trials.

Type 1 diabetes in your family or community?

This Friday we’re hosting a ResearchFriends conversation with the St Vincent’s team behind world-leading diabetes technology research.

Everyone’s welcome (it's free). Link in comments.

14/11/2025

This , we'd like to highlight this wonderful video of our study nurse and coordinator Jenna, who lives with Type 1 Diabetes. A number of our team members, including Jenna, have lived experience of managing diabetes in the workplace. Their dedication to advocacy and improving clinical outcomes for those living with diabetes are exceptional assets for our team, helping us to offer the best clinical care to our participants.

13/11/2025

Today is .
As part of the World Diabetes Day focus on diabetes and well-being, this year the International Diabetes Federation is calling for more inclusive and supportive workplaces where people with diabetes feel supported. By strengthening awareness and understanding, we can ensure workplaces where people living with diabetes feel safe, valued, and empowered to thrive.

13/11/2025

We are looking for people with type 1 diabetes and impaired hypoglycemia awareness to take part in a research study at St Vincent’s Hospital, Melbourne.
To enquire, please contact DTRG-t1research@unimelb.edu.au or 03 9231 2757.
Alternatively, follow this link to our website to express your interest:
https://www.diabetestechnologyresearchgroup.com.au/the-CLEAR-study/

30/10/2025

Important Notice for Potential Research Participants!
We appreciate your overwhelming interest in our research projects over the past few weeks!
Unfortunately, our "get in touch" form on our website experienced a malfunction, and submissions made before Tuesday 28th October were not received.
If you have recently made an enquiry, please resubmit your details so we can contact you!

https://www.diabetestechnologyresearchgroup.com.au/get-involved/

Thank you!

Get Involved with the D.T.R.G Diabetes clinical trials are an essential part of the development of new interventions

24/10/2025

Great news! D.T.R.G have been awarded a prestigious NIH Award, which will fund a new project investigating the use of SGLT inhibitors in people with type 1 diabetes! This project will be lead by Professor David O'Neal, Dr Dale Morrison, and Dr Audrey Kong (pictured left to right).

SGLT inhibitors have transformed the management of type 2 diabetes, saving countless lives by improving glycaemic control and significantly reducing cardiovascular and renal complications. However, their use in T1D has been limited due to the increased risk of diabetic ketoacidosis (DKA) when taking SGLT inhibitors, which can be life threatening.

This study will evaluate whether continuous glucose and ketone monitoring, combined with a tailored response algorithm, can help detect rising ketone levels early and prevent DKA, while allowing people with T1D to experience the many benefits SGLT inhibitors offer.

We are very excited to be bringing this study to Australians living with T1D, and we look forward to sharing the results of this important project in the future!

23/09/2025

Last week, D.T.R.G attended , represented by Dr David O'Neal, Dr Jean Lu, and Dr Jennifer Ngan. Pictured here is Dr Jennifer Ngan giving her presentation on the preliminary results of our PARTNER study, which involves the investigation of free-living ketone profiles collected by continuous ketone monitors in people with type 1 diabetes. To learn more about the findings of this investigation and for access to the publication, follow this link to our website - https://www.diabetestechnologyresearchgroup.com.au/dr-jennifer-ngan-presents-at-easd-2025/

23/09/2025

D.T.R.G are currently recruiting for the COYOTE study, investigating if using an automated insulin delivery system can improve glucose levels in people with type 2 diabetes. For any enquiries, please contact us on dtrg-t1research@unimelb.edu.au or visit our website at https://www.diabetestechnologyresearchgroup.com.au/the-coyote-study/

16/09/2025

This important trial is currently recruiting participants. To check your eligibility, follow the link to the Diabetes Victoria website:
https://www.diabetesvic.org.au/news-research/take-part-in-research-trials/research-trials-type-1-diabetes/mt-101-101-trial-for-type-1-diabetes/

The MT-101-101 study is a phase 1 clinical trial, testing the safety and dosing of a new treatment for autoimmune diseases including type 1 diabetes. They are looking for people:
🔵 Aged between 18 and 45 years
🔵 Diagnosed with type 1 diabetes
🔵 Residual C-peptide (a measure of insulin production
🔵 Currently using insulin (via injections or by pump)
🔵 Living in Victoria or NSW

If you match this criteria and are interested in being involved, click through and find out more >>> https://bit.ly/4poFcCe